Erratum: Role of STAT3 and Vitamin D receptor in EZH2-mediated invasion of human colorectal cancer (Journal of Pathology (2013) 230 (277-290) DOI: 10.1002/path.4179);Role of STAT3 and vitamin D receptor in EZH2 -mediated invasion of human colorectal cancer

Journal of Pathology

Volumn 230, Issue 3, 2013, Pages 277-290

  Lin, Yan Wei ^a   Ren, Lin Lin ^a   Xiong, Hua ^a   Du, Wan ^a   Yu, Ya Nan ^a   Sun, Tian Tian ^a   Weng, Yu Rong ^a   Wang, Zhen Hua ^a   Wang, Ji Lin ^a   Wang, Ying Chao ^a   Cui, Yun ^a   Sun, Dan Feng ^a   Han, Ze Guang ^b   Shen, Nan ^a   Zou, Weiping ^c   Xu, Jie ^a   Chen, Hao Yan ^a   Cao, Weibiao ^d   Hong, Jie ^a   Fang, Jing Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

colorectal cancer; EZH2; invasion; vitamin D receptor, STAT3

Indexed keywords

GELATINASE A; GELATINASE B; LYSINE; STAT3 PROTEIN; TRANSCRIPTION FACTOR EZH2; UVOMORULIN; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL INVASION; CELL MOTILITY; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; HISTONE METHYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR INVASION;

EID: 84878791222     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4698     Document Type: Erratum

References (47)

1. Bates RC, Mercurio AM,. The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther 2005; 4: 365-370. (Pubitemid 41351251)
2. Markowitz SD, Dawson DM, Willis J, et al,. Focus on colon cancer. Cancer Cell 2002; 1: 233-236. (Pubitemid 41039147)
3. Fearon ER,. Molecular genetics of colorectal cancer. Annu Rev Pathol 2011; 6: 479-507.
4. van Engeland M, Derks S, Smits KM, et al,. Colorectal cancer epigenetics: complex simplicity. J Clin Oncol 2011; 29: 1382-1391.
5. de Krijger I, Mekenkamp LJ, Punt CJ, et al,. MicroRNAs in colorectal cancer metastasis. J Pathol 2011; 224: 438-447.
6. Kirmizis A, Bartley SM, Farnham PJ,. Identification of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy. Mol Cancer Ther 2003; 2: 113-121.
7. Sasaki M, Ikeda H, Itatsu K, et al,. The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma. Lab Invest 2008; 88: 873-882.
8. Varambally S, Dhanasekaran SM, Zhou M, et al,. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419: 624-629.
9. Simon JA, Lange CA,. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 2008; 647: 21-29.
10. Cao R, Wang L, Wang H, et al,. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 2002; 298: 1039-1043. (Pubitemid 35247314)
11. Kirmizis A, Bartley SM, Kuzmichev A, et al,. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev 2004; 18: 1592-1605. (Pubitemid 38868910)
12. Fang J, Zhang M, Li Q,. Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and invasion in cervical cancer. Am J Med Sci 2011; 342: 198-204.
13. Shin YJ, Kim JH,. The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells. PLoS One 2012; 7: e30393.
14. Deeb KK, Trump DL, Johnson CS,. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nature Rev Cancer 2007; 7: 684-700. (Pubitemid 47327412)
15. Haussler MR, Norman AW,. Chromosomal receptor for a vitamin D metabolite. Proc Natl Acad Sci U S A 1969; 62: 155-162.
16. Palmer HG, Gonzalez-Sancho JM, Espada J, et al,. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 2001; 154: 369-387. (Pubitemid 34286147)
17. Vleminckx K, Vakaet L Jr, Mareel M, et al,. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66: 107-119. (Pubitemid 121001351)
18. Shabahang M, Buras RR, Davoodi F, et al,. 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res 1993; 53: 3712-3718. (Pubitemid 23252030)
19. Larriba MJ, Martin-Villar E, Garcia JM, et al,. Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer. Carcinogenesis 2009; 30: 1459-1468.
20. Evans SR, Nolla J, Hanfelt J, et al,. Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer. Clin Cancer Res 1998; 4: 1591-1595. (Pubitemid 28304718)
21. Bachmann IM, Halvorsen OJ, Collett K, et al,. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol 2006; 24: 268-273. (Pubitemid 46622055)
22. Fujii S, Tokita K, Wada N, et al,. MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes. Oncogene 2011; 30: 4118-4128.
23. Varambally S, Cao Q, Mani RS, et al,. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008; 322: 1695-1699.
24. Gupta RA, Shah N, Wang KC, et al,. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-1076.
25. Spano JP, Milano G, Rixe C, et al,. JAK/STAT signalling pathway in colorectal cancer: a new biological target with therapeutic implications. Eur J Cancer 2006; 42: 2668-2670. (Pubitemid 44584670)
26. Lassmann S, Schuster I, Walch A, et al,. STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation. J Clin Pathol 2007; 60: 173-179.
27. Xiong H, Zhang ZG, Tian XQ, et al,. Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia 2008; 10: 287-297. (Pubitemid 351328587)
28. Yeh HY, Cheng SW, Lin YC, et al,. Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency. BMC Med Genomics 2009; 2: 70.
29. Velichutina I, Shaknovich R, Geng H, et al,. EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis. Blood 2010; 116: 5247-5255.
30. Langlois MJ, Bergeron S, Bernatchez G, et al,. The PTEN phosphatase controls intestinal epithelial cell polarity and barrier function: role in colorectal cancer progression. PLoS One 2010; 5: e15742.
31. Samuels Y, Diaz LA Jr, Schmidt-Kittler O, et al,. Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 2005; 7: 561-573. (Pubitemid 40799249)
32. Chang CJ, Yang JY, Xia W, et al,. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling. Cancer Cell 2011; 19: 86-100.
33. Rao ZY, Cai MY, Yang GF, et al,. EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients. Carcinogenesis 2010; 31: 1576-1583.
34. Tong ZT, Cai MY, Wang XG, et al,. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin. Oncogene 2012; 31: 583-594.
35. Cao Q, Yu J, Dhanasekaran SM, et al,. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 2008; 27: 7274-7284.
36. Huang C, Yang G, Jiang T, et al,. The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro. Neoplasma 2011; 58: 396-405.
37. Yadav A, Kumar B, Datta J, et al,. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res 2011; 9: 1658-1667.
38. Raman JD, Mongan NP, Tickoo SK, et al,. Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder. Clin Cancer Res 2005; 11: 8570-8576. (Pubitemid 43005902)
39. Chen Y, Lin MC, Yao H, et al,. Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin. Hepatology 2007; 46: 200-208. (Pubitemid 47171937)
40. Fujii S, Ito K, Ito Y, et al,. Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation. J Biol Chem 2008; 283: 17324-17332.
41. Shabahang M, Buras RR, Davoodi F, et al,. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3. Cancer Res 1994; 54: 4057-4064.
42. Eisman JA, Barkla DH, Tutton PJ,. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res 1987; 47: 21-25. (Pubitemid 17002091)
43. Spina CS, Ton L, Yao M, et al,. Selective vitamin D receptor modulators and their effects on colorectal tumor growth. J Steroid Biochem Mol Biol 2007; 103: 757-762. (Pubitemid 46420525)
44. Matusiak D, Murillo G, Carroll RE, et al,. Expression of vitamin D receptor and 25-hydroxyvitamin D3-1α-hydroxylase in normal and malignant human colon. Cancer Epidemiol Biomarkers Prev 2005; 14: 2370-2376. (Pubitemid 41437839)
45. Ng K, Meyerhardt JA, Wu K, et al,. Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 2008; 26: 2984-2991.
46. Xiong H, Hong J, Du W, et al,. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. J Biol Chem 2012; 287: 5819-5832.
47. Gire V, Roux P, Wynford-Thomas D, et al,. DNA damage checkpoint kinase Chk2 triggers replicative senescence. EMBO J 2004; 23: 2554-2563. (Pubitemid 38988227)